Protective effect of ethosuximide on hearing in NOD/LtJ mice via blockage of endogenous apoptosis

  • Dejun Zhang
  • Guofang Guan
  • Yingyuan Guo
  • Yanru Hao
  • Fang Guo
  • Zeming Fu
Keywords: Ethosuximide, Endogenous apoptosis, Hearing, Protection

Abstract

Purpose: To determine the protective effect of ethosuximide on the hearing of NOD/LtJ mice, and the underlying mechanism of action.

Methods: The mice were randomly assigned to control and treatment groups (20 mice per group). Mice in the treatment group were administered ethosuximide intraperitoneally at a dose of 200mg/kg body weight (bwt), while those in the control group received an equivalent dose of saline via the same route. Both groups were subjected to auditory brainstem response (ABR) and distortion product otoacoustic emissions (DPOAE) tests, as well as determination of mRNA expressions of α1G, α1H, α1I, m-calpain, μ-calpain, and caspase-3.

Results: At ages of 6 and 9 weeks, ABR values were significantly lower in the treatment group than those in the control group (p < 0.05). At age 3, 6 and 9 weeks, control group DPOAE values were much lower than those in the treatment group. However, at signal frequency of 35344 Hz, DPOAE value was significantly reduced in the treatment group (p < 0.05). There was significant down-regulation in mRNA expressions of α1G, α1H, α1I, m-calpain, μ-calpain and caspase-3, in the treatment group, when compared with the control group (p < 0.05).

Conclusion: Ethosuximide delays mice hearing loss and protects their hearing via a mechanism involving blockage of endogenous apoptotic pathways. This mechanism may provide guidance in the search for suitable new drugs.

Keywords: Ethosuximide, Endogenous apoptosis, Hearing, Protection

Published
2020-04-09
Section
Articles

Journal Identifiers


eISSN: 1596-9827
print ISSN: 1596-5996